The oncogenic fusion protein EML4-NTRK3 requires three salt bridges for stability and biological activity.

Coiled coil Congenital mesoblastic nephroma Infantile fibrosarcoma Oncogenic fusion protein Soft tissue sarcoma

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 15 09 2023
revised: 07 08 2024
accepted: 13 08 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: epublish

Résumé

Chromosomal translocations involving neurotrophic receptor tyrosine kinases (NTRKs) have been identified in 20 % of soft tissue sarcomas. This work focuses on the EML4-NTRK3 translocation identified in cases of Infantile Fibrosarcoma, which contains the coiled-coil multimerization domain of Echinoderm Microtubule-like protein 4 (EML4) fused with the tyrosine kinase domain of Neurotrophic Receptor Tyrosine Kinase 3 (NTRK3). The aim of the study was to test the importance of tyrosine kinase activity and multimerization for the oncogenic activity of EML4-NTRK3. These studies examined EML4-NTRK3 proteins containing a kinase-dead or WT kinase domain, together with mutations in specific salt bridge residues within the coiled-coil domain. Biological activity was assayed using focus assays in NIH3T3 cells. The MAPK/ERK, JAK/STAT3 and PI3K/AKT pathways were analyzed for downstream activation of signaling pathways. Localization of EML4-NTRK3 proteins was examined by immunofluorescence microscopy, and the ability of the EML4 coiled-coil domain to drive protein multimerization was examined by biochemical assays. Activation of EML4-NTRK3 relies on both the tyrosine kinase activity of NTRK3 and salt-bridge stabilization within the coiled-coil domain of EML4. The tyrosine kinase activity of NTRK3 is essential for the biological activation of EML4-NTRK3. Furthermore, EML4-NTRK3 activates downstream signaling pathways MAPK/ERK, JAK/STAT3 and PKC/PLCγ. The disruption of three specific salt bridge interactions within the EML4 coiled-coil domain of EML4-NTRK3 blocks downstream activation, biological activity, and the ability to hetero-multimerize with EML4. We also demonstrate that EML4-NTRK3 is localized in the cytoplasm and fails to associate with microtubules. These data suggest potential therapeutic strategies for Infantile Fibrosarcoma cases bearing EML4-NTRK3 fusion through inhibition of salt bridge interactions and disruption of multimerization.

Identifiants

pubmed: 39253179
doi: 10.1016/j.heliyon.2024.e36278
pii: S2405-8440(24)12309-2
pmc: PMC11381775
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e36278

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Zian Jiang (Z)

Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093-0367 USA.

April N Meyer (AN)

Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093-0367 USA.

Wei Yang (W)

Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093-0367 USA.

Daniel J Donoghue (DJ)

Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093-0367 USA.
UCSD Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093-0367, USA.

Classifications MeSH